Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 24-Jan-24 5:25 PM View:  | Orchard Therapeutics Plc (ORTX) | 24-Jan-24 | Disposition | 12,294 | -- | -- | (100%) 12.29K to 0 | |
| 05-Dec-23 4:30 PM View: | Generation Bio Co. (GBIO) | 04-Dec-23 | Purchase | 150,000 | $1.50 | $225,000.00 | 39% 384.76K to 534.76K | |
| 05-Dec-23 4:30 PM View: | Generation Bio Co. (GBIO) | 01-Dec-23 | Private Purchase | 192,960 | $1.31 | $252,778.00 | 101% 191.8K to 384.76K | |
| 18-May-23 6:31 PM View: | Viking Therapeutics, Inc. (VKTX) | 16-May-23 | Option Exercise | 40,000 | $1.08 | $43,200.00 | 133% 30.0K to 70.0K | |
| 18-May-23 6:31 PM View: | Viking Therapeutics, Inc. (VKTX) | 16-May-23 | Planned Option Sale | 40,000 | $25.00 | $1,000,000.00 | (57%) 70.0K to 30.0K | |
| 20-Sep-22 4:16 PM View: | Generation Bio Co. (GBIO) | 19-Sep-22 | Private Purchase | 15,750 | $5.26 | $82,845.00 | 9% 176.05K to 191.8K | |
| 19-Sep-22 5:21 PM View: | Generation Bio Co. (GBIO) | 16-Sep-22 | Purchase | 33,481 | $5.48 | $183,476.00 | 23% 142.57K to 176.05K | |
| 19-Sep-22 5:21 PM View: | Generation Bio Co. (GBIO) | 15-Sep-22 | Private Purchase | 17,147 | $5.41 | $92,765.30 | 14% 125.42K to 142.57K | |
| 15-Sep-22 4:07 PM View: | Generation Bio Co. (GBIO) | 14-Sep-22 | Purchase | 5,600 | $5.30 | $29,652.00 | 5% 119.82K to 125.42K | |
| 15-Sep-22 4:07 PM View: | Generation Bio Co. (GBIO) | 13-Sep-22 | Private Purchase | 18,784 | $5.20 | $97,751.90 | 19% 101.03K to 119.82K | |
| 03-Aug-22 9:48 PM View: | Nabriva Therapeutics Plc (NBRV) | 01-Aug-22 | Sale | 8,496 | $0.17 | $1,486.80 | (36%) 23.77K to 15.28K | |
| 04-Aug-21 9:05 PM View: | Nabriva Therapeutics Plc (NBRV) | 02-Aug-21 | Market Sale | 777 | $1.20 | $932.40 | (3%) 24.55K to 23.77K | (2%) |
| 30-Jul-21 8:21 PM View: | Nabriva Therapeutics Plc (NBRV) | 28-Jul-21 | Grant | 17,500 | -- | -- | 248% 7.05K to 24.55K | |
| 04-Jun-21 4:16 PM View: | Blueprint Medicines Corp (BPMC) | 02-Jun-21 | Grant | 2,250 | -- | -- | 63% 3.56K to 5.81K | |
| 13-Jan-21 4:04 PM View: | Generation Bio Co. (GBIO) | 11-Jan-21 | Private Purchase | 20,408 | $24.50 | $499,996.00 | 25% 80.63K to 101.03K | |
| 18-Dec-20 4:09 PM View: | Blueprint Medicines Corp (BPMC) | 17-Dec-20 | Option Exercise | 10,909 | $19.53 | $213,053.00 | 306% 3.56K to 14.47K | |
| 18-Dec-20 4:09 PM View: | Blueprint Medicines Corp (BPMC) | 17-Dec-20 | Market Option Sale | 10,909 | $117.82 | $1,285,300.00 | (75%) 14.47K to 3.56K | 18% |
| 04-Nov-20 5:18 PM View: | Blueprint Medicines Corp (BPMC) | 03-Nov-20 | Option Exercise | 5,522 | $9.46 | $52,238.10 | 155% 3.56K to 9.08K | |
| 04-Nov-20 5:18 PM View: | Blueprint Medicines Corp (BPMC) | 03-Nov-20 | Market Option Sale | 5,522 | $98.73 | $545,196.00 | (61%) 9.08K to 3.56K | 2% |
| 04-Nov-20 5:18 PM View: | Blueprint Medicines Corp (BPMC) | 02-Nov-20 | Option Exercise | 4,478 | $9.46 | $42,361.90 | 126% 3.56K to 8.04K | |
| 04-Nov-20 5:18 PM View: | Blueprint Medicines Corp (BPMC) | 02-Nov-20 | Market Option Sale | 4,478 | $99.11 | $443,815.00 | (56%) 8.04K to 3.56K | 3% |
| 31-Jul-20 4:55 PM View: | Nabriva Therapeutics Plc (NBRV) | 29-Jul-20 | Grant | 17,500 | -- | -- | 33% 53.0K to 70.5K | |
| 26-Jun-20 4:10 PM View: | Blueprint Medicines Corp (BPMC) | 24-Jun-20 | Grant | 2,250 | -- | -- | 171% 1.31K to 3.56K | |
| 23-Jun-20 4:15 PM View: | Blueprint Medicines Corp (BPMC) | 19-Jun-20 | Option Exercise | 1,312 | -- | -- | 100% 0 to 1.31K | |
| 18-Jun-20 5:30 PM View: | Generation Bio Co. (GBIO) | 16-Jun-20 | Conversion | 50,627 | -- | -- | 100% 0 to 50.63K | |
| 18-Jun-20 5:30 PM View: | Generation Bio Co. (GBIO) | 16-Jun-20 | Purchase | 30,000 | $19.00 | $570,000.00 | 59% 50.63K to 80.63K | |
| 24-Jun-19 8:08 PM View: | Blueprint Medicines Corp (BPMC) | 20-Jun-19 | Option Exercise | 11,818 | $9.46 | $111,798.00 | 100% 0 to 11.82K | |
| 24-Jun-19 8:08 PM View: | Blueprint Medicines Corp (BPMC) | 20-Jun-19 | Market Option Sale | 11,818 | $95.15 | $1,124,460.00 | (100%) 11.82K to 0 | (1%) |
| 27-Dec-18 4:05 PM View: | Nabriva Therapeutics Plc (NBRV) | 24-Dec-18 | Market Purchase | 53,000 | $1.31 | $69,430.00 | 100% 0 to 53.0K | (79%) |
| 31-May-18 7:02 PM View: | Viking Therapeutics, Inc. (VKTX) | 29-May-18 | Market Purchase | 30,000 | $5.16 | $154,800.00 | 100% 0 to 30.0K | 20% |
| 30-Aug-16 4:39 PM View: | Dnib Unwind, Inc. (BIND) | 26-Aug-16 | Option Exercise | 15,000 | $0.44 | $6,600.00 | 100% 0 to 15.0K | |
| 28-Jan-14 8:35 PM View: | ViroPharma Inc. (VPHM) | 24-Jan-14 | Grant | 48,878 | -- | -- | 56% 87.03K to 135.9K | |
| 28-Jan-14 8:35 PM View: | ViroPharma Inc. (VPHM) | 24-Jan-14 | Disposition | 48,878 | -- | -- | (36%) 135.9K to 87.03K | |
| 28-Jan-14 8:35 PM View: | ViroPharma Inc. (VPHM) | 24-Jan-14 | Disposition (change in control) | 87,026 | $50.00 | $4,351,300.00 | (100%) 87.03K to 0 | < 1% |
| 10-Jan-14 1:34 PM View: | ViroPharma Inc. (VPHM) | 08-Jan-14 | Payment of Exercise | 6,449 | $49.80 | $321,160.00 | (7%) 93.47K to 87.03K | (< 1%) |
| 10-Jan-14 1:34 PM View: | ViroPharma Inc. (VPHM) | 08-Jan-14 | Option Exercise | 28,753 | $9.50 | $273,157.00 | 44% 64.72K to 93.47K | |
| 31-Dec-13 4:33 PM View: | ViroPharma Inc. (VPHM) | 27-Dec-13 | Payment of Exercise | 704 | $49.86 | $35,101.40 | (1%) 65.43K to 64.72K | < 1% |
| 31-Dec-13 4:33 PM View: | ViroPharma Inc. (VPHM) | 27-Dec-13 | Option Exercise | 4,540 | $5.91 | $26,831.40 | 7% 60.89K to 65.43K | |
| 20-Dec-13 4:13 PM View: | ViroPharma Inc. (VPHM) | 18-Dec-13 | Payment of Exercise | 25,129 | $49.74 | $1,249,920.00 | (29%) 86.02K to 60.89K | (< 1%) |
| 20-Dec-13 4:13 PM View: | ViroPharma Inc. (VPHM) | 18-Dec-13 | Option Exercise | 49,006 | $9.26 | $453,673.00 | 132% 37.01K to 86.02K | |
| 09-Mar-12 4:08 PM View: | ViroPharma Inc. (VPHM) | 07-Mar-12 | Payment of Exercise | 12,715 | $29.49 | $374,965.00 | (27%) 47.76K to 35.05K | (69%) |
| 09-Mar-12 4:08 PM View: | ViroPharma Inc. (VPHM) | 07-Mar-12 | Option Exercise | 30,638 | $12.24 | $374,985.00 | 179% 17.13K to 47.76K | |
| 05-Mar-12 4:01 PM View: | ViroPharma Inc. (VPHM) | 01-Mar-12 | Option Exercise | 70,000 | $9.99 | $699,200.00 | 234% 29.88K to 99.88K | |
| 05-Mar-12 4:01 PM View: | ViroPharma Inc. (VPHM) | 01-Mar-12 | Market Option Sale | 70,000 | $32.12 | $2,248,150.00 | (70%) 99.88K to 29.88K | (55%) |
| 05-Mar-12 4:01 PM View: | ViroPharma Inc. (VPHM) | 01-Mar-12 | Market Sale | 12,750 | $32.12 | $409,484.00 | (43%) 29.88K to 17.13K | (55%) |
| 15-Mar-11 4:50 PM View: | ViroPharma Inc. (VPHM) | 14-Mar-11 | Option Exercise | 35,000 | $8.02 | $280,600.00 | 123% 28.5K to 63.5K | |
| 15-Mar-11 4:50 PM View: | ViroPharma Inc. (VPHM) | 14-Mar-11 | Market Option Sale | 35,000 | $18.57 | $649,950.00 | (55%) 63.5K to 28.5K | (168%) |
| 27-Feb-09 11:56 AM View: | ViroPharma Inc. (VPHM) | 26-Feb-09 | Market Purchase | 16,000 | $4.78 | $76,521.80 | 200% 8.0K to 24.0K | 951% |
| 05-Nov-08 3:56 PM View: | ViroPharma Inc. (VPHM) | 03-Nov-08 | Market Purchase | 8,000 | $12.77 | $102,160.00 | 100% 0 to 8.0K | 293% |
| 25-Feb-08 5:16 PM View: | Endo Pharmaceuticals Holdin... (ENDP) | 21-Feb-08 | Grant | 6,699 | -- | -- | 100% 0 to 6.7K |